Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Publication year range
1.
Rev. argent. reumatol ; 27(1): 14-24, 2016. tab
Article in Spanish | LILACS | ID: biblio-831276

ABSTRACT

Introducción: El proyecto BIOBADASAR (Registro argentino deeventos adversos con tratamientos biológicos en reumatología)comenzó en agosto de 2010, para recabar información a largo plazosobre los eventos adversos en tratamientos biológicos en pacientescon enfermedades reumáticas en la práctica clínica cotidiana enArgentina.Pacientes y método: Se registraron datos de cada paciente,tratamientos y acontecimientos adversos relevantes o importantes.Los pacientes debían tener enfermedad diagnosticada y tratadacon un agente biológico. Cada caso se comparó con un control:un paciente con tratamiento no biológico con característicasdemográficas similares. Se analizaron los datos con análisis de lavarianza, con test de t de Student, Mann Whitney, test chi2, o testexacto de Fisher. El análisis de supervivencia de los tratamientoshasta su discontinuación o interrupción se realizó con el método deKaplan-Meier y test log-rank...


Background: BIOBADASAR (Argentine Registry of Adverse Eventsin Biological Treatments in Rheumatology) was started in August2010 to obtain long-term information of patients with rheumatic diseases,treatments and adverse events in everyday clinical practice.Patients and methods: Data on patients’ demographics,treatments and adverse events were collected. Patients had a diagnosisof a rheumatic disease and were treated with biological agent.To compare information, a control group was included, consisting ofpatients treated with similar demographic characteristics but treatedwith a non-biological agent. Data were analysed with Anova,Student´s t, Mann Whitney, chi2, Fisher´s exact tests, as appropriate.Survival analysis of treatments was performed with Kaplan-Meiercurves and log-rank test...


Subject(s)
Biological Treatment , Rheumatic Diseases , Rheumatology
2.
Adv Perit Dial ; 15: 193-6, 1999.
Article in English | MEDLINE | ID: mdl-10682100

ABSTRACT

The purpose of our study was to compare the incidence of peritonitis between continuous ambulatory peritoneal dialysis (CAPD) treatment (Group I) and automated peritoneal dialysis (APD) treatment (Group II) taking into account the same population. We compared 20 patients with a follow-up of 215 patient-months on CAPD and 252 patient-months on APD. Demographic data, diagnosis, peritoneal equilibration test (PET) results, adequacy, and peritonitis rate were analyzed. Diagnoses included glomerulopathy 35%, autosomal dominant polycystic kidney disease (ADPKD) 20%, Type II diabetes 10%, systemic lupus erythematosus 5%, interstitial nephritis 5%, nephrolitiasis 5%, and unknown 20%. PET results showed that the group consisted of 30% high transporters, 45% high-average transporters, and 25% low-average transporters. Kt/V for Group I was 1.3 +/- 0.3, and for Group II, 1.83 +/- 0.48. Creatinine clearance for Group I was 43.64 +/- 7.31 L/week/1.73 m2, and for Group II, 52.42 +/- 13.47 L/week/1.73 m2. Group I presented a peritonitis rate of 8.3 episodes/patient-month, and Group II presented a rate of 18.9 episodes/patient-month. Gram-positive organisms were responsible for 49.8% of episodes of peritonitis in Group I (S. aureus 26.6%, S. epidermidis 16.6%, others 10%) and 83% of peritonitis episodes in Group II (S. epidermidis 46.6%, S. aureus 20%). Gram-negative organisms were responsible for 16.5% of episodes of peritonitis in Group I. No gram-negative peritonitis was seen in Group II. APD patients developed two cases of candida peritonitis. Our preliminary results show that Group II exhibited a decrease in peritonitis rate while achieving better adequacy. In CAPD and APD peritonitis, gram-positive organisms predominated. In APD, we observed an increase in S. epidermidis incidence. No gram-negative organisms were observed in APD. It seems that APD is a safer treatment owing to the lower peritonitis incidence.


Subject(s)
Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritoneal Dialysis/adverse effects , Peritonitis/etiology , Adult , Aged , Diabetes Mellitus, Type 2/therapy , Follow-Up Studies , Glomerulonephritis/therapy , Humans , Kidney Calculi/therapy , Lupus Erythematosus, Systemic/therapy , Middle Aged , Nephritis, Interstitial/therapy , Peritonitis/microbiology , Polycystic Kidney, Autosomal Dominant/therapy
3.
Arch Inst Cardiol Mex ; 45(4): 445-52, 1975.
Article in Spanish | MEDLINE | ID: mdl-1180608

ABSTRACT

Four cases of aorto-pulmonary window are presented, diagnosed in the Section of Pediatric Cardiology during the last six years. The results obtained from clinic; ECG; X-ray; hemodinamic and angiographic studies are described. All of them were clinically diagnosed as left to right shunt through a persistent ductus arteriosus in two cases and of VSD the other two. The final diagnosis was made through cardiac cateterization in one case and at surgery in three. Two of the cases showed additional alterations, in one case it was a PDA, and the other a valvular aortic stenosis. All of them were operated, three successfully and one died immediately after operation. We consider that the study of this relatively rare cardiopaty deserves special attention, because of the similarity to other forms of left to right shunts. We insist on its difficult clinical dianose and the need of making a early diagnosis to do corrective surgery.


Subject(s)
Ductus Arteriosus, Patent , Heart Septal Defects, Ventricular , Angiocardiography , Cardiac Catheterization , Child, Preschool , Cineangiography , Ductus Arteriosus, Patent/diagnosis , Electrocardiography , Female , Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/surgery , Heart Septal Defects, Ventricular/diagnosis , Heart Septal Defects, Ventricular/surgery , Humans , Infant , Phonocardiography , Pulmonary Artery/abnormalities
SELECTION OF CITATIONS
SEARCH DETAIL